A diagnosis of idiopathic hypereosinophilic syndrome was made in a 68-year-old woman in 2002. A diagnostic work-up including radiological evaluation failed to reveal an overt lymphoproliferative disorder. Currently, 6 months after the revised diagnosis, the patient is well with an eosinophil count of 0.3 · 109/l on alemtuzumab (30 mg) every 3 weeks.
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report
PITINI, Vincenzo;TETI, Diana;ARRIGO, Carmela;RIGHI, Maria
2004-01-01
Abstract
A diagnosis of idiopathic hypereosinophilic syndrome was made in a 68-year-old woman in 2002. A diagnostic work-up including radiological evaluation failed to reveal an overt lymphoproliferative disorder. Currently, 6 months after the revised diagnosis, the patient is well with an eosinophil count of 0.3 · 109/l on alemtuzumab (30 mg) every 3 weeks.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.